Prostacyclin (PGI 2 ), the major product of cyclooxygenase in macrovascular endothelium, mediates its biological effects through its cell surface G protein-coupled receptor, the IP. PKC-mediated phosphorylation of human (h) IP is a critical determinant of agonist-induced desensitization (Smyth, E. M., Hong Li, W., and FitzGerald, G. A. (1998) J. Biol. Chem. 273, 23258 -23266). The regulatory events that follow desensitization are unclear. We have examined agonist-induced sequestration of hIP. Human IP, tagged at the N terminus with hemagglutinin (HA) and fused at the C terminus to the green fluorescent protein (GFP), was coupled to increased cAMP (EC 50 ؍ 0.39 ؎ 0.09 nM) and inositol phosphate (EC 50 ؍ 86.6 ؎ 18.3 nM) generation when overexpressed in HEK 293 cells. Iloprost-induced sequestration of HAhIP-GFP, followed in real time by confocal microscopy, was partially colocalized to clathrin-coated vesicles. Iloprost induced a time-and concentration-dependent loss of cell surface HA, indicating receptor internalization, which was prevented by inhibitors of clathrin-mediated trafficking and partially reduced by cotransfection of cells with a dynamin dominant negative mutant. Sequestration (EC 50 ؍ 27.6 ؎ 5.7 nM) was evident at those concentrations of iloprost that induce PKC-dependent desensitization. Neither the PKC inhibitor GF109203X nor mutation of Ser-328, the site for PKC phosphorylation, altered receptor sequestration indicating that, unlike desensitization, internalization is PKC-independent. Deletion of the C terminus prevented iloprostinduced internalization, demonstrating the critical nature of this region for sequestration. Internalization was unaltered by cotransfection of cells with G proteincoupled receptor kinases (GRK)-2, -3, -5, -6, arrestin-2, or an arrestin-2 dominant negative mutant, indicating that GRKs and arrestins do not play a role in hIP trafficking. The hIP is sequestered in response to agonist activation via a PKC-independent pathway that is distinct from desensitization. Trafficking is dependent on determinants located in the C terminus, is GRK/arrestin-independent, and proceeds in part via a dynamin-dependent clathrin-coated vesicular endocytotic pathway although other dynamin-independent pathways may also be involved.Prostacyclin (PGI 2 ) 1 is the major product of cyclooxygenase (COX) in macrovascular endothelium (1). In humans, the predominant source of prostacyclin biosynthesis is COX-2 (2, 3), probably reflecting induction of its expression in endothelium by physiological rates of shear (4). COX-2 is also up-regulated in vascular cells by cytokines and growth factors (5), and both COX isoforms are coexpressed in monocyte/macrophages infiltrating human atherosclerotic plaque (6). PGI 2 inhibits platelet activation, is a vasodilator, and possesses proinflammatory and antiproliferative properties in vitro (7-9). It is thought to function as a homeostatic regulator of platelet-vascular interactions in settings of plaque rupture, such as unstable angina, where biosynthesis of P...